Discover free eBooks, guides and med spa templates on our new resources page

Book a demo
☰
Why us
ICD Hub / Certain conditions originating in the perinatal period (P00–P96) / KA00.9 - Fetus or newborn affected by maternal chemotherapy
ICD-11

ICD-11 Codes
for KA00.9 - Fetus or newborn affected by maternal chemotherapy
Teodor Jurukovski January 1, 1970
Fact checked by: Teodor Jurukovski
Use Code

Understanding Fetus or Newborn Affected by Maternal Chemotherapy

This condition, identified by the ICD-11 code KA00.9, describes a situation where a fetus or newborn is affected due to the mother receiving chemotherapy during pregnancy. Chemotherapy involves medications used to treat cancer and certain other conditions. These medications can cross the placenta, potentially impacting fetal development and the newborn's health.

Maternal Chemotherapy and Pregnancy Risks

The primary cause for this diagnosis is the administration of chemotherapy to the mother during her pregnancy. Chemotherapeutic agents can cross the placental barrier, posing risks to the developing fetus. The specific risks and their severity can depend on several factors, including the type of chemotherapy used, the dosage, the duration of treatment, and crucially, the stage of pregnancy when the chemotherapy is administered. Exposure during the first trimester is often associated with a higher risk of birth defects and miscarriage, while later-term exposure may increase the likelihood of preterm birth, low birth weight, or temporary issues with the newborn's blood cell counts.

Diagnosing Fetus or Newborn Affected by Maternal Chemotherapy

The diagnosis of a fetus or newborn affected by maternal chemotherapy is typically made based on the mother's medical history of receiving chemotherapy during pregnancy. Medical professionals will assess the fetus and newborn for any potential effects. Diagnostic approaches may include prenatal ultrasounds to monitor fetal growth and screen for structural abnormalities. Postnatal evaluations of the newborn are essential to identify any health issues that may have arisen due to the in-utero exposure.

Managing Pregnancy with Maternal Chemotherapy

When chemotherapy is necessary during pregnancy, management strategies focus on minimising risks to the fetus and newborn. Healthcare providers often aim to avoid chemotherapy during the first trimester if possible, as the risk of birth defects is generally lower in the second and third trimesters. Treatment decisions are made by weighing the benefits of managing the mother's condition against the potential risks to the pregnancy. Close monitoring of both the mother and the fetus is crucial throughout the pregnancy. It is generally advised that breastfeeding is not undertaken while the mother is receiving chemotherapy due to potential risks to the infant.

Coding and Documentation for KA00.9

The ICD-11 code for Fetus or newborn affected by maternal chemotherapy is KA00.9. This code falls under the broader category of 'Fetus or newborn affected by maternal factors or by complications of pregnancy, labour or delivery' (KA00-KA0Z). Accurate documentation is vital for correct coding, ensuring that the impact of maternal chemotherapy on the fetus or newborn is appropriately recorded for medical records, statistical purposes, and billing. This ICD-11 code is reportable for morbidity statistics.

When to Seek Medical Advice

Pregnant individuals undergoing or considering chemotherapy, or those who have received it during pregnancy, should seek prompt medical advice. Any concerns regarding the potential effects of chemotherapy on the fetus or newborn warrant consultation with healthcare professionals. Early discussion with medical providers can help in understanding the risks, benefits, and management options available.

Frequently asked questions

What is the ICD-11 classification meaning of KA00.9?
KA00.9 is the ICD-11 code for a fetus or newborn affected by maternal chemotherapy.
When is the ICD-11 code KA00.9 used?
The ICD-11 code KA00.9 is used to classify conditions where a fetus or newborn is affected by chemotherapy administered to the mother.
How is the condition of a fetus or newborn being affected by maternal chemotherapy classified in ICD-11?
This condition is classified under the ICD-11 code KA00.9, which specifically denotes a fetus or newborn affected by maternal chemotherapy.
×